Shanghai Fosun Pharmaceutical Group Co Ltd (600196) — Free Cash Flow Generation Index
Shanghai Fosun Pharmaceutical Group Co Ltd (600196) has a Free Cash Flow Generation Index of 0.47x as of December 2025. Free cash flow of CN¥1.12 Billion represents 0% of operating cash flow (CN¥2.40 Billion). See Shanghai Fosun Pharmaceutical Group Co L short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Shanghai Fosun Pharmaceutical Group Co Ltd Free Cash Flow Generation Index (1998–2025)
Historical FCF Generation Index trend for Shanghai Fosun Pharmaceutical Group Co Ltd across 28 annual periods. Explore 600196 operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Shanghai Fosun Pharmaceutical Group Co Ltd (1998–2025)
Year-by-year Free Cash Flow Generation Index for Shanghai Fosun Pharmaceutical Group Co Ltd. For the full company profile including market capitalisation, see Shanghai Fosun Pharmaceutical Group Co L (600196) market capitalisation.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.26x | CN¥1.56 Billion | CN¥6.01 Billion | CN¥4.45 Billion | ▲ +1637.7% |
| 2024 | 0.01x | CN¥66.79 Million | CN¥4.48 Billion | CN¥4.41 Billion | ▲ +103.4% |
| 2023 | -0.44x | CN¥-1.92 Billion | CN¥4.36 Billion | CN¥5.34 Billion | ▼ -11.2% |
| 2022 | -0.40x | CN¥-1.67 Billion | CN¥4.22 Billion | CN¥5.89 Billion | ▼ -52.8% |
| 2021 | -0.26x | CN¥-1.02 Billion | CN¥3.95 Billion | CN¥4.97 Billion | ▲ +64.0% |
| 2020 | -0.72x | CN¥-1.86 Billion | CN¥2.58 Billion | CN¥4.44 Billion | ▼ -213.7% |
| 2019 | -0.23x | CN¥-739.65 Million | CN¥3.22 Billion | CN¥3.96 Billion | ▼ -201.2% |
| 2018 | -0.08x | CN¥-224.81 Million | CN¥2.95 Billion | CN¥3.17 Billion | ▼ -148.0% |
| 2017 | 0.16x | CN¥409.61 Million | CN¥2.58 Billion | CN¥2.17 Billion | ▲ +78.1% |
| 2016 | 0.09x | CN¥188.08 Million | CN¥2.11 Billion | CN¥1.92 Billion | ▼ -62.5% |
| 2015 | 0.24x | CN¥385.49 Million | CN¥1.62 Billion | CN¥1.24 Billion | ▲ +253.3% |
| 2014 | 0.07x | CN¥80.78 Million | CN¥1.20 Billion | CN¥1.12 Billion | ▲ +339.6% |
| 2013 | -0.03x | CN¥-28.42 Million | CN¥1.01 Billion | CN¥1.04 Billion | ▲ +96.2% |
| 2012 | -0.74x | CN¥-495.08 Million | CN¥665.52 Million | CN¥1.16 Billion | ▲ +50.9% |
| 2011 | -1.52x | CN¥-480.18 Million | CN¥316.65 Million | CN¥796.83 Million | ▼ -127.1% |
| 2010 | -0.67x | CN¥-135.81 Million | CN¥203.36 Million | CN¥339.17 Million | ▼ -102.9% |
| 2009 | -0.33x | CN¥-86.20 Million | CN¥261.87 Million | CN¥348.07 Million | ▼ -442.3% |
| 2008 | 0.10x | CN¥22.41 Million | CN¥233.04 Million | CN¥210.63 Million | ▲ +116.2% |
| 2007 | -0.59x | CN¥-78.23 Million | CN¥131.48 Million | CN¥209.71 Million | ▼ -34.7% |
| 2006 | -0.44x | CN¥-81.69 Million | CN¥184.91 Million | CN¥266.61 Million | ▼ -142.9% |
| 2005 | -0.18x | CN¥-34.26 Million | CN¥188.35 Million | CN¥222.60 Million | ▼ -43884.5% |
| 2004 | 0.00x | CN¥85.20K | CN¥205.10 Million | CN¥205.02 Million | ▲ +100.1% |
| 2003 | -0.76x | CN¥-113.92 Million | CN¥150.14 Million | CN¥264.05 Million | ▼ -109.9% |
| 2002 | -0.36x | CN¥-37.05 Million | CN¥102.47 Million | CN¥139.52 Million | ▲ +66.4% |
| 2001 | -1.08x | CN¥-73.35 Million | CN¥68.15 Million | CN¥141.51 Million | ▼ -1362.5% |
| 2000 | 0.09x | CN¥11.80 Million | CN¥138.43 Million | CN¥126.63 Million | ▲ +108.2% |
| 1999 | -1.04x | CN¥-39.79 Million | CN¥38.20 Million | CN¥77.99 Million | ▼ -584.7% |
| 1998 | 0.21x | CN¥14.30 Million | CN¥66.55 Million | CN¥52.25 Million | — |